← FDA Drug Approvals (Drugs@FDA)
AMLODIPINE AND OLMESARTAN MEDOXOMIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2018-12-03
Drug application
- FDA Application #
ANDA209010- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMLODIPINE AND OLMESARTAN MEDOXOMIL
- Generic name
- AMLODIPINE AND OLMESARTAN MEDOXOMIL
- Active ingredients
- AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SCIEGEN PHARMS
- Manufacturer
- ScieGen Pharmaceuticals, Inc
- First approval
- 2018-12-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown